Jadran Galenski Laboratorij (JGL) is one of the leading Croatian pharmaceutical companies, headquartered in Rijeka. From 1991. to date, thanks to its innovative strategies, the company has been continuously growing. The company’s strategy of fast growth has been based on the development of its own brand of generic drugs, as well as on strategic partnerships with some of the major pharmaceutical companies in development, production and marketing.
This European pharmaceutical company was experiencing rapid growth that was not supported by its existing controlling processes. The company’s budgeting and forecasting processes were manual, time-consuming and labor-intensive. Reporting, planning and forecasting were difficult and often inaccurate because data was scattered across the company, which lacked a single view of market data, competitors, procurement and production information. The company needed to implement a fact-driven planning process enabled by an in-depth analysis of all available data.
Read entire case study here: